Geriatric Medicine Development- Potential Market To Target

Geriatric Medicine Development - Carving out New Opportunities to Treat Age-related Diseases @ http://www.reportsnreports.com/reports/280698-geriatric-medicine-development-carving-out-new-opportunities-to-treat-age-related-diseases.html
There remains a lack of clinical data to support prescription decisions as relatively few medicines have been clinically evaluated in age-appropriate patients. In addition, many drugs are not available in formulations that are suitable for the elderly, leading to non-compliance and lack of therapeutic efficacy. In 2011, the EMA introduced its Geriatric Medicines Strategy to ensure that the medical requirements of older people are identified earlier in the drug development process. In 2012, the ICH E7 guidelines were revised to include a greater focus on involving more geriatric patients in drug trials.